Analyst stock forecast
Genmab Forecast: $44.40 Analyst Target
Direct answer
Genmab's average price target is $44.40.
The target implies +20.4% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies -9.2%, the high target implies +57.2%, and the range spans 66.4% of the current price.
Forecast evidence checked October 15, 2026.
Get free Genmab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $36.89
- Average price target
- $44.40
- High price target
- $58.00
- Low price target
- $33.50
- Low target gap
- -9.2%
- Target upside
- +20.4%
- High target gap
- +57.2%
- Target range width
- 66.4%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- October 15, 2026
- Valid through
- October 22, 2026
Explore related company data
Read the frequently asked questions.
What is Genmab's average price target?
Genmab's verified average price target is $44.40. The target range is $33.50 to $58.00.
How far are Genmab's low and high targets from the recorded price?
The low target implies -9.2%, while the high target implies +57.2%.
How many analysts are included in Genmab's consensus?
The verified consensus includes 11 analysts.
How is Genmab's target upside or downside calculated?
The average target of $44.40 is divided by the recorded price of $36.89, then one is subtracted to produce +20.4%. This does not guarantee a future return.
When was Genmab's analyst forecast verified?
The data was verified on 2026-10-15. The dataset is valid through 2026-10-22.